<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Infectious Diseases and Microbiology</journalTitle>
<eissn>2328-4064</eissn>
<publicationDate>2025-08-25</publicationDate>
<volume>13</volume>
<issue>3</issue>
<startPage>51</startPage>
<endPage>55</endPage>
<doi>10.12691/ajidm-13-3-2</doi>
<publisherRecordId>AJIDM20251332</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Rapid Score as a Prognostic Factor for Patients with Empyema in a Tertiary Care Center - A Prospective Observational Study</title>
<authors>
<author>
<name>Abishek Ravichandran</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Saka Vinod Kumar</name>
<email>vinoddayamani@hotmail.com</email>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Manju R</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Rakhi Biswas</name>
<affiliationId>2</affiliationId>
</author>
<author>
<name>Sharbari Basu</name>
<affiliationId>3</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Department of Pulmonary Medicine, Jawaharlal Institute of PostgraduateMedical Education and Research (JIPMER), Puducherry, India</affiliationName>


<affiliationName affiliationId="2">Department of Microbiology, Jawaharlal Institute of PostgraduateMedical Education and Research (JIPMER), Puducherry, India</affiliationName>
<affiliationName affiliationId="3">Department of Biochemistry, Jawaharlal Institute of PostgraduateMedical Education and Research (JIPMER), Puducherry, India</affiliationName>
</affiliationsList>
<abstract language="eng">Background: Empyema is a serious pleural infection with significant morbidity and mortality. The RAPID score is a validated tool for early risk stratification. This study aimed to evaluate the prognostic value of the RAPID score in adult empyema patients in a tertiary care setting. Methods: A prospective observational study was conducted on 61 adult patients with confirmed empyema. RAPID scores were assigned at admission to stratify patients into low (0¨C2), medium (3¨C4), and high (5¨C7) risk groups. Clinical features, microbiological profile, radiological findings, need for surgery, hospital stay, and 3-month mortality were recorded and analysed. Results:Most patients were male (82%) and aged &lt;50 years (52.5%). Diabetes (42.6%) and tuberculosis (26.2%) were prevalent; Pseudomonas aeruginosa (19.7%) was the most common isolate. RAPID scores classified 65.6% as low risk, 29.5% as medium, and 4.9% as high. Unadjusted analysis showed higher mortality in medium-risk vs. low-risk groups (27.8% vs. 5%; p = 0.026), with no deaths in the high-risk group. On multivariable logistic regression, medium risk had higher but non-significant odds of mortality (aOR 8.03; 95% CI 0.61¨C105.13; p = 0.112); subgroup analysis suggested a stronger association in non-TB empyema (aOR 13.67; p = 0.061). Only age was independently associated with mortality (p = 0.014). RAPID score was not associated with hospital stay or surgical intervention. Conclusion: The RAPID score is a useful bedside tool for predicting short-term mortality in empyema, particularly in medium-risk patients, though it does not predict hospital stay or surgical need. Age was the strongest individual predictor of mortality.</abstract>
<fullTextUrl format="pdf">https://pubs.sciepub.com/ajidm/13/3/2/ajidm-13-3-2.pdf</fullTextUrl>
<keywords language="eng"><keyword>Empyema</keyword>
<keyword>RAPID score</keyword>
<keyword>Pleural infection</keyword>
<keyword>Mortality prediction</keyword>
<keyword>Surgical intervention</keyword>
</keywords>
</record>
</records>
